Literature DB >> 19826276

Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remission.

Robert Burakoff1, Scott Hande, Jun Ma, Peter A Banks, Sonia Friedman, Frederick Makrauer, Choong-Chin Liew.   

Abstract

GOALS: Assessment of disease severity is a frequent challenge in the management of Crohn's disease. Noninvasive, accurate markers for monitoring disease activity are urgently required. Specific gene expression patterns and molecular biomarkers associated with active Crohn's disease could serve as such markers, thereby providing a novel approach to disease activity monitoring.
BACKGROUND: Gene expression profiling in circulating leukocytes has shown promise in several medical conditions and blood may provide an easily accessible surrogate tissue for using gene expression profiling to assess activity of Crohn's disease. STUDY: In this study, we compared genome-wide transcription profiles of circulating leukocytes in patients with active and quiescent Crohn's disease.
RESULTS: We observed complex changes in blood gene expression patterns in active Crohn's disease: genes of various functional categories were differentially regulated between active and inactive Crohn's disease. We specifically identified a number of inflammatory molecules overexpressed or underexpressed in active Crohn's disease and validated a subset of these genes by real-time reverse transcription-polymerase chain reaction.
CONCLUSIONS: The genes differentially regulated in peripheral leukocytes represent potential new biomarkers for assessing the activity of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19826276     DOI: 10.1097/MCG.0b013e3181a9ef53

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

Review 1.  New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.

Authors:  Edward L Barnes; Robert Burakoff
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

Review 2.  Potential value of nutrigenomics in Crohn's disease.

Authors:  Lynnette R Ferguson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-13       Impact factor: 46.802

3.  Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.

Authors:  Edward L Barnes; Choong-Chin Liew; Samuel Chao; Robert Burakoff
Journal:  World J Gastrointest Endosc       Date:  2015-11-25

4.  Gene expression signature for detection of gastric cancer in peripheral blood.

Authors:  Jianing Shi; Changming Cheng; Jun Ma; Choong-Chin Liew; Xiaoping Geng
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

5.  Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.

Authors:  Jerzy Ostrowski; Michalina Dabrowska; Izabella Lazowska; Agnieszka Paziewska; Aneta Balabas; Anna Kluska; Maria Kulecka; Jakub Karczmarski; Filip Ambrozkiewicz; Magdalena Piatkowska; Krzysztof Goryca; Natalia Zeber-Lubecka; Jaroslaw Kierkus; Piotr Socha; Michal Lodyga; Maria Klopocka; Barbara Iwanczak; Katarzyna Bak-Drabik; Jaroslaw Walkowiak; Piotr Radwan; Urszula Grzybowska-Chlebowczyk; Bartosz Korczowski; Teresa Starzynska; Michal Mikula
Journal:  J Crohns Colitis       Date:  2019-04-26       Impact factor: 9.071

Review 6.  The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease.

Authors:  Zahra Alghoul; Chunhua Yang; Didier Merlin
Journal:  Biomedicines       Date:  2022-06-24

7.  Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.

Authors:  Adel M Zaatar; Chun Ren Lim; Chin Wei Bong; Michelle Mei Lin Lee; Jian Jiek Ooi; David Suria; Rakesh Raman; Samuel Chao; Hengxuan Yang; Soon Bin Neoh; Choong-Chin Liew
Journal:  J Exp Clin Cancer Res       Date:  2012-09-17

8.  Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.

Authors:  Samuel Chao; Jay Ying; Gailina Liew; Wayne Marshall; Choong-Chin Liew; Robert Burakoff
Journal:  J Exp Clin Cancer Res       Date:  2013-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.